rifampin

Product NDC
70518-3199
11-digit product format
705183199
Labeler code
70518
Product ID
70518-3199_ca3aa7a8-9d27-3d66-e053-2a95a90a05be
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
rifampin
Dosage form
CAPSULE
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA090034
Marketing category
ANDA
Marketing start
2021-08-21
Marketing end
0000-00-00
Substance
RIFAMPIN
Active strength
150 mg/1
Pharmacologic classes
Rifamycin Antibacterial [EPC],Rifamycins [CS]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-3199-02023-03-21C16284748780-1f386c649-c79e-0266-e053-dadaa90a7c1a6f7c7a01-3ea2-4b18-82cd-8cae48d17f5a
70518-3199-02023-01-30C16284748780-1f386c649-c79e-0266-e053-dadaa90a7c1a6f7c7a01-3ea2-4b18-82cd-8cae48d17f5a

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-3199-07051831990030 CAPSULE in 1 BLISTER PACK (70518-3199-0) 30 capsule2021-08-210000-00-00NoNoCurrent